11:46:38 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2024-06-05 Bokslutskommuniké 2024
2024-02-29 Kvartalsrapport 2024-Q3
2024-02-26 Halvårsutdelning EKTA B 1.2
2023-11-30 Kvartalsrapport 2024-Q2
2023-08-25 Halvårsutdelning EKTA B 1.2
2023-08-24 Årsstämma 2024
2023-08-24 Kvartalsrapport 2024-Q1
2023-05-25 Bokslutskommuniké 2023
2023-02-24 Halvårsutdelning EKTA B 1.2
2023-02-24 Kvartalsrapport 2023-Q3
2022-11-24 Kvartalsrapport 2023-Q2
2022-08-26 Halvårsutdelning EKTA B 1.2
2022-08-25 Årsstämma 2023
2022-08-25 Kvartalsrapport 2023-Q1
2022-05-25 Bokslutskommuniké 2022
2022-02-24 Kvartalsrapport 2022-Q3
2022-02-24 Halvårsutdelning EKTA B 1.1
2021-11-25 Kvartalsrapport 2022-Q2
2021-08-26 Halvårsutdelning EKTA B 1.1
2021-08-25 Kvartalsrapport 2022-Q1
2021-08-25 Årsstämma 2022
2021-05-28 Bokslutskommuniké 2021
2021-04-19 Bonusutdelning EKTA B 0.9
2021-04-16 Extra Bolagsstämma 2021
2021-02-25 Kvartalsrapport 2021-Q3
2020-11-26 Kvartalsrapport 2021-Q2
2020-08-27 Halvårsutdelning EKTA B 0.9
2020-08-26 Årsstämma 2021
2020-08-26 Kvartalsrapport 2021-Q1
2020-05-29 Bokslutskommuniké 2020
2020-02-21 Halvårsutdelning EKTA B 0.9
2020-02-20 Kvartalsrapport 2020-Q3
2019-11-28 Kvartalsrapport 2020-Q2
2019-08-23 Halvårsutdelning EKTA B 0.9
2019-08-22 Årsstämma 2020
2019-08-22 Kvartalsrapport 2020-Q1
2019-05-29 Bokslutskommuniké 2019
2019-03-01 Halvårsutdelning EKTA B 0.7
2019-02-22 Kvartalsrapport 2019-Q3
2018-11-29 Kvartalsrapport 2019-Q2
2018-08-31 Halvårsutdelning EKTA B 0.7
2018-08-30 Kvartalsrapport 2019-Q1
2018-08-30 Årsstämma 2019
2018-06-01 Bokslutskommuniké 2018
2018-03-02 Kvartalsrapport 2018-Q3
2018-02-22 Halvårsutdelning EKTA B 0.5
2017-11-30 Kvartalsrapport 2018-Q2
2017-08-24 Halvårsutdelning EKTA B 0.5
2017-08-23 Årsstämma 2018
2017-08-23 Kvartalsrapport 2018-Q1
2017-06-01 Bokslutskommuniké 2017
2017-03-03 Halvårsutdelning EKTA B 0.25
2017-03-01 Kvartalsrapport 2017-Q3
2016-12-01 Kvartalsrapport 2017-Q2
2016-09-26 Kapitalmarknadsdag 2016
2016-09-02 Halvårsutdelning EKTA B 0.25
2016-09-01 Årsstämma 2017
2016-09-01 Kvartalsrapport 2017-Q1
2016-06-01 Bokslutskommuniké 2016
2016-03-02 Kvartalsrapport 2016-Q3
2015-12-03 Kvartalsrapport 2016-Q2
2015-09-02 Ordinarie utdelning EKTA B 0.50 SEK
2015-09-01 Kvartalsrapport 2016-Q1
2015-09-01 Årsstämma 2016
2015-06-02 Bokslutskommuniké 2015
2015-03-04 Kvartalsrapport 2015-Q3
2014-11-27 Kvartalsrapport 2015-Q2
2014-11-27 Analytiker möte 2014
2014-09-15 Kapitalmarknadsdag 2014
2014-08-29 Ordinarie utdelning EKTA B 1.50 SEK
2014-08-29 Bonusutdelning EKTA B 0.5
2014-08-28 Kvartalsrapport 2015-Q1
2014-08-28 Analytiker möte 2015
2014-08-28 Årsstämma 2015
2014-05-28 Analytiker möte 2014
2014-05-28 Bokslutskommuniké 2014
2014-02-27 Kvartalsrapport 2014-Q3
2013-12-04 Kvartalsrapport 2014-Q2
2013-09-23 Kapitalmarknadsdag 2013
2013-09-04 Ordinarie utdelning EKTA B 1.50 SEK
2013-09-04 Bonusutdelning EKTA B 0.5
2013-09-03 Kvartalsrapport 2014-Q1
2013-09-03 Årsstämma 2014
2013-06-05 Bokslutskommuniké 2013
2013-06-05 Analytiker möte 2013
2013-03-05 Extra Bolagsstämma 2013
2013-03-05 Kvartalsrapport 2013-Q3
2012-12-04 Kvartalsrapport 2013-Q2
2012-10-29 Kapitalmarknadsdag 2012
2012-09-12 Split EKTA B 1:4
2012-09-05 Ordinarie utdelning EKTA B 5.00 SEK
2012-09-03 Årsstämma 2013
2012-09-03 Kvartalsrapport 2013-Q1
2012-06-05 Analytiker möte 2012
2012-06-05 Bokslutskommuniké 2012
2012-04-02 Extra Bolagsstämma 2012
2012-03-05 Kvartalsrapport 2012-Q3
2011-12-02 Kvartalsrapport 2012-Q2
2011-09-14 Ordinarie utdelning EKTA B 4.00 SEK
2011-09-13 Årsstämma 2012
2011-09-13 Kvartalsrapport 2012-Q1
2011-06-09 Bokslutskommuniké 2011
2011-03-08 Kvartalsrapport 2011-Q3
2010-12-07 Kvartalsrapport 2011-Q2
2010-09-22 Ordinarie utdelning EKTA B 3.00 SEK
2010-09-21 Kvartalsrapport 2011-Q1
2010-06-09 Bokslutskommuniké 2010
2010-03-10 Kvartalsrapport 2009-Q3
2009-12-10 Kvartalsrapport 2009-Q2
2009-09-16 Ordinarie utdelning EKTA B 2.00 SEK
2009-09-15 Årsstämma 1
2009-09-15 Kvartalsrapport 2009-Q1
2008-09-19 Ordinarie utdelning EKTA B 1.75 SEK
2007-09-26 Ordinarie utdelning EKTA B 1.00 SEK
2006-09-21 Ordinarie utdelning EKTA B 1.00 SEK
2005-10-17 Split EKTA B 1:3
2005-09-22 Ordinarie utdelning EKTA B 6.60 SEK
2004-09-22 Ordinarie utdelning EKTA B 0.00 SEK
2003-09-23 Ordinarie utdelning EKTA B 0.00 SEK
2002-10-01 Ordinarie utdelning EKTA B 0.00 SEK
2001-09-28 Ordinarie utdelning EKTA B 0.00 SEK
2000-10-02 Ordinarie utdelning EKTA B 0.00 SEK
1999-09-23 Ordinarie utdelning EKTA B 0.00 SEK

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Elekta är verksamma inom medicinteknik. Bolaget är specialiserade inom utveckling av kliniska lösningar för behandling av cancer och hjärnsjukdomar. Elektas behandlingssystem och planeringsmjukvara för strålterapi och strålkirurgi samt övriga mjukvarusystem används inom sjukhusindustrin för att identifiera och analysera olika hälsotillstånd. Verksamhet innehas på global nivå, med huvudkontor i Stockholm.
2019-08-22 17:00:00

STOCKHOLM, August 22, 2019 - The Annual General Meeting re-elected all Board members except Annika Espander Jansson, who had declined re-election. Among other business, the Annual General Meeting resolved to pay a dividend of SEK 1.80 per share and to introduce a new performance-based share program.

The Annual General Meeting adopted the following resolutions:

Dividend and appropriation of the Company's profits
Of the Company's unappropriated earnings totaling SEK 2,550,414,301, a per-share dividend of SEK 1.80 to be distributed to the shareholders. The remaining amount is to be carried forward. The dividend will be divided into two payments, of SEK 0.90 per payment. The first record date for the dividend was determined Monday, August 26, 2019 and the second record day was determined as Monday, February 24, 2020. The payments are expected to be made on Thursday, August 29, 2019 and on Thursday, February 27, 2020.

Adoption of the income statement and balance sheet
The Annual General Meeting adopted the income statement and balance sheet for the Parent Company, as well as the consolidated income statement and consolidated balance sheet as of April 30, 2019. The members of the Board and the CEO were discharged from liability for the fiscal year 2018/19.

Board of Directors and committees
The Annual General Meeting resolved that the Board of Directors shall consist of eight members without deputies. Laurent Leksell, Caroline Leksell Cooke, Johan Malmquist, Tomas Puusepp, Wolfgang Reim, Jan Secher, Birgitta Stymne Göransson and Cecilia Wikström were re-elected as members of the Board. Laurent Leksell was re-elected as Chairman of the Board.

The following director fees were adopted: SEK 1,280,000 (1,165,000) to the Chairman of the Board, SEK 550,000 (500,000) to each external member of the Board, SEK 115,000 (110,000) to the Chairman and SEK 80,000 (75,000) to other members of the Company's Executive Compensation & Capability Committee, SEK 240,000 (225,000) to the Chairman and SEK 150,000 (135,000) to other members of the Company's Audit Committee. No Board Members employed by the Company shall receive remuneration or compensation for committee work.

Auditors
The Annual General Meeting elected the registered public auditing firm Ernst & Young AB ("EY"), as auditor for the period until the end of the Annual General Meeting 2020. EY has informed the Nomination Committee that if EY is elected, the Authorized Public Accountant Rickard Andersson will be appointed as auditor in charge. Fees will be paid according to an approved account.

Guidelines for remuneration to the Executive Management
The Annual General Meeting approved the guidelines for remuneration and other employment conditions for Executive Management. The guidelines apply for employment contracts that become effective after the Annual General Meeting's resolution and in the event that changes are made to existing contracts after this date.

Performance Share Plan 2019
The Annual General Meeting resolved to adopt Performance Share Plan 2019. The program comprises the President and CEO, Executive Management and nominated Key Contributors, all in all about 30 employees, who will qualify for allotment, free of charge, of shares of series B following expiry of the three-year performance period and provided continued employment in the Group until the end of the Performance Year 2021/2022. The total number of shares that can be allotted is dependent on the degree of fulfilment of one target, Elekta three-year Total Shareholder Return ("TSR") relative to the OMXS30 Index over a three-year period. For the Performance Share Plan 2019, the minimum performance requirement is that Elekta TSR outperform the OMXS30 Index with at least +0.1 per cent. The maximum performance level requires that Elekta TSR outperform the OMXS30 Index at or above +15 per cent. The performance target shall be adjusted at the occurrence of events affecting the number of outstanding shares in the Company, or unforeseen material events affecting the Elekta Group's operations or otherwise affecting the performance targets and deemed relevant by the Board of Directors. Should the Company decide on changes to the Company's accounting principles or decide on restructuring costs, the Board of Directors may decide on changes to the Performance Share Plan 2019 performance targets. 

Assuming maximum allotment under the Performance Share Plan 2019 and a share price of SEK 120, a maximum of 715,356 shares of series B are required to fulfil commitments under the program (including social security costs), corresponding to approximately 0.19 per cent of the total number of outstanding shares. Under the above assumptions, the estimated costs, including social security costs and the financing cost for repurchased own shares, are approximately SEK 85,842,715.

Acquisition and transfer of own shares
The Annual General Meeting authorized the Board of Directors, during the period until the next Annual General Meeting to resolve, on one or more occasions, on the acquisition of a maximum number of own shares so that, after the acquisitions, the Company does not hold more than ten per cent of the total number of shares in the Company. The Annual General Meeting also authorized the Board of Directors, during the period until the next Annual General Meeting to resolve, on one or more occasions, on transfers of own shares in connection with financing company acquisitions and other strategic investments and transfers, and not exceeding the maximum number of treasury shares held by the Company at any given time.

In view of the Performance Share Plan 2019, the Annual General Meeting resolved to approve the Board of Director's proposal on transfer of treasury shares amounting to not more than 800,000 shares of series B, and to authorize the Board of Directors, during the period until the next Annual General Meeting, on one or more occasions, to make decisions that not more than 240,000 shares will be transferred on Nasdaq Stockholm with the purpose of covering certain fees, primarily social security costs.

In view of the Performance Share Plan 2017 and 2018, the Annual General Meeting authorized the Board of Directors during the period until the next Annual General Meeting, on one or more occasions, to decide that not more than 240,000 shares will be transferred on Nasdaq Stockholm with the purpose of covering certain fees, primarily social security costs.

# # #
 

For further information, please contact:
Cecilia Ketels, Head of Investor Relations, Elekta AB
Tel: +46 76 611 76 25, e-mail: cecilia.ketels@elekta.com 
Time zone: CET: Central European Time

The information was published at 17:00 CET on August 22, 2019. (REGMAR)

About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com (http://www.elekta.com) or follow @Elekta (https://twitter.com/Elekta)on Twitter.